Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock and derivative securities.
Summary
- On July 8, 2024, John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in his beneficial ownership of the company's securities.
- The report includes transactions related to phantom units, employee stock options, and restricted stock units.
- Corkrean directly owns 47,187 shares of common stock.
- He also holds various employee stock options with different exercise prices and expiration dates, totaling 237,178 options.
- Additionally, he owns restricted stock units that convert into common stock on a 1-for-1 basis, with vesting schedules over three years.
Sentiment
Score: 5
Explanation: This is a routine filing, and the information itself doesn't inherently indicate positive or negative sentiment. It simply reflects changes in the executive's holdings.
Positives
- The reporting of beneficial ownership changes provides transparency to investors.
- The executive's holdings of company stock and options align his interests with those of shareholders.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. This filing is consistent with standard practices for publicly traded companies.
Comparison to Industry Standards
- Executive compensation packages often include a mix of salary, stock options, and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules and exercise prices of the options and restricted stock units are typical for executive compensation plans in similar companies.
- Comparing the total equity compensation of H.B. Fuller's executives to that of peers like Avery Dennison or 3M would provide a more comprehensive assessment.
Stakeholder Impact
- Shareholders can use this information to understand the alignment of management's interests with their own.
- Employees may be interested in the details of the stock option and restricted stock unit plans.
- The filing itself has minimal direct impact on customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of employee stock option exercisable with an exercise price of $43.48 and expiring on 05/17/2026. |
| 01/26/2018 | Date of employee stock option exercisable with an exercise price of $50.1 and expiring on 01/26/2027. |
| 01/25/2019 | Date of employee stock option exercisable with an exercise price of $53.57 and expiring on 01/25/2028. |
| 01/24/2020 | Date of employee stock option exercisable with an exercise price of $45.05 and expiring on 01/24/2029. |
| 01/24/2021 | Date of employee stock option exercisable with an exercise price of $48.35 and expiring on 01/24/2030. |
| 01/27/2022 | Date of employee stock option exercisable with an exercise price of $51.89 and expiring on 01/27/2031. |
| 01/24/2023 | Date of employee stock option exercisable with an exercise price of $72.94 and expiring on 01/24/2032, and the start date for vesting of restricted stock units. |
| 01/24/2024 | Date of employee stock option exercisable with an exercise price of $68.17 and expiring on 01/24/2033, and the start date for vesting of restricted stock units. |
| 01/26/2025 | Date of employee stock option exercisable with an exercise price of $77.72 and expiring on 01/26/2034, and the start date for vesting of restricted stock units. |
| 07/05/2024 | Date of transaction for phantom units. |
| 07/08/2024 | Date of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.